(Q73362834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

main subject

phase II clinical trial

1 reference

1 reference

R S Witte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Lipsitz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T L Goodman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R F Asbury

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Wilding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

C M Strnad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

T J Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D G Haller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

173-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10638488%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006327418043

3 November 2019

exact match

0 references

cites work

Cancer statistics, 1998.

1 reference

12 December 2020

Continuous infusion homoharringtonine (NSC 141633) in refractory acute nonlymphocytic leukemia. An ECOG pilot study

1 reference

12 December 2020

Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia

1 reference

12 December 2020

Phase I trial of caracemide using bolus and infusion schedules

1 reference

12 December 2020

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

1 reference

12 December 2020

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

1 reference

12 December 2020

Structures of harringtonine, isoharringtonine, and homoharringtonine

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study

1 reference

12 December 2020

Phase II study of homoharringtonine in patients with recurrent primary malignant central nervous system tumors

1 reference

12 December 2020

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study

1 reference

12 December 2020

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

12 December 2020

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

1 reference

12 December 2020

Current approaches to metastatic colorectal cancer.

1 reference

12 December 2020

Phase II study of caracemide in advanced or recurrent non-small cell lung cancer

1 reference

12 December 2020